The Ferumoxytol for Anemia of CKD Trial (FACT)—a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale

BACKGROUND: Iron deficiency anemia (IDA) is a common manifestation of chronic kidney disease (CKD), affecting most patients on hemodialysis and imposing a substantial clinical burden. Treatment with iron supplementation increases hemoglobin levels and can reduce the severity of anemia in patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Macdougall, Iain C., Dahl, Naomi V., Bernard, Kristine, Li, Zhu, Batyky, Alka, Strauss, William E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379516/
https://www.ncbi.nlm.nih.gov/pubmed/28372549
http://dx.doi.org/10.1186/s12882-017-0523-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379516/
https://www.ncbi.nlm.nih.gov/pubmed/28372549
http://dx.doi.org/10.1186/s12882-017-0523-8

Ejemplares similares